Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06692673 · ClinicalTrials.gov registry record · Phase 1
Linaclotide for Colonoscopy Bowel Prep
A Phase 1 study of Patients Scheduled for Colonoscopy, sponsored by University of Florida.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06692673 is a Phase 1 study of Patients Scheduled for Colonoscopy that is actively recruiting participants, run by University of Florida. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06692673, a Phase 1 study of Patients Scheduled for Colonoscopy, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if drug Linaclotide can be used as a single agent regimen to adequately prepare bowel for colonoscopy. The main question it aims to answer is: Does drug Linaclotide with Gatorade provide adequate bowel preparation for colonoscopy instead of the standard 4 Liters of Polyethylene glycol (PEG)? Participants will: Take one 290mg dose of Linaclotide 36 hours before the procedure and One 290mg dose of Linaclotide 8 hours before the procedure + 2 Liters of Gatorade and a clear liquid diet 24 hours before the procedure. As per standard of care, all patients will be made Nil Per Oral (NPO) starting midnight before the procedure. The colonoscopy report will then be reviewed for Boston Bowel Preparation Score (BBPS) as a marker of bowel preparation quality, insertion time as a marker of procedure difficulty as well as noted pathology and any complications or physician noted comments.
Conditions Studied
Interventions
- DRUG Use of Linaclotide as a single agent Colonoscopy prep
Study Locations (1)
Florida
- UF Health - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06692673
The ClinicalTrials.gov registry entry for NCT06692673 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patients Scheduled for Colonoscopy appearing as the primary indexed condition, and to 1 intervention - of which Use of Linaclotide as a single agent Colonoscopy prep is the first listed.
NCT06692673 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06692673 about?
NCT06692673 is a clinical study titled "Linaclotide for Colonoscopy Bowel Prep". The goal of this clinical trial is to learn if drug Linaclotide can be used as a single agent regimen to adequately prepare bowel for colonoscopy. The main question it aims to answer is: Does drug Linaclotide with Gatorade provide adequate bowel preparation for colonoscopy instead of the standard ...
What is the current status of trial NCT06692673?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-12-01. Estimated completion is 2026-07-28.
What conditions does trial NCT06692673 study?
This clinical trial studies the following conditions: Patients Scheduled for Colonoscopy.
What interventions are being tested in trial NCT06692673?
The interventions under investigation include: Use of Linaclotide as a single agent Colonoscopy prep (DRUG).
Who is sponsoring clinical trial NCT06692673?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06692673 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.